You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KURA Sale Disclosure
Doyle Thomas James · SEC Form 4 · Filed Sep 29, 2026
Sale
Calculated transaction value
$48.36K
Doyle Thomas James SVP, Finance & Accounting
KURA
Kura Oncology
KURA
Transaction date
Sep 28, 2026
Public filing date
Sep 29, 2026
Filing lag
Filed 1 day later
KURA daily price context
Close on/before transaction
$10.61
Sep 28, 2026
First close after public filing
$10.71
Sep 30, 2026
30-day return after filing
-1.4%
Through Oct 29, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,607 shares @ $10.5
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-407936
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$48.36K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kura Oncology, Inc. KURA Current | Sale | Sep 28, 2026 | $48.36K |